Search by Drug Name or NDC

    NDC 69097-0828-05 Quinapril and Hydrochlorothiazide 10/12.5 12.5; 10 mg/1; mg/1 Details

    Quinapril and Hydrochlorothiazide 10/12.5 12.5; 10 mg/1; mg/1

    Quinapril and Hydrochlorothiazide 10/12.5 is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE.

    Product Information

    NDC 69097-0828
    Product ID 69097-828_4d3f7e7a-ed61-4df6-bc45-f38fb4117406
    Associated GPIs 36991802650320
    GCN Sequence Number 019140
    GCN Sequence Number Description quinapril/hydrochlorothiazide TABLET 10-12.5 MG ORAL
    HIC3 A4J
    HIC3 Description ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC
    GCN 54160
    HICL Sequence Number 007826
    HICL Sequence Number Description QUINAPRIL HCL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Quinapril and Hydrochlorothiazide 10/12.5
    Proprietary Name Suffix n/a
    Non-Proprietary Name quinapril and Hydrochlorothiazide 10/12.5
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201356
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0828-05 (69097082805)

    NDC Package Code 69097-828-05
    Billing NDC 69097082805
    Package 90 TABLET in 1 BOTTLE (69097-828-05)
    Marketing Start Date 2016-07-20
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1de5420c-23d6-40c5-ba24-39143c0f90fb Details

    Revised: 1/2022